Showing results (541-550 of 2,332) with videos related to
Sort By:
Pageof 234
Microsurgery|January 1, 1993
Novel microsurgical model of experimental vascular neointimal hyperplasiaM Tennant, A Barker, A E Storrie, et al.The British Journal of Dermatology|May 1, 1977
Failure of prostaglandins, prostaglandin metabolites and arachidonic acid to elicit chemotaxis of human polymorphonuclear leukocytesA Pazzaglia, A Barker, A P Warin, et al.Expert Reviews in Molecular Medicine|February 28, 2004
Modern therapeutic approaches in Parkinson's diseaseSimon J G Lewis, Maeve A Caldwell, Roger A BarkerJournal of Neurology|March 3, 2005
The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's diseaseCarrie B Hurelbrink, Simon J G Lewis, Roger A BarkerMovement Disorders : Official Journal of the Movement Disorder Society|October 8, 2005
Huntington's disease patients have selective problems with insightAileen K Ho, Anna O G Robbins, Roger A BarkerNeurobiology of Disease|December 26, 2006
The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesiasWei-Li Kuan, Rachel Lin, Pam Tyers, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 2, 2017
Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuitsAleksandra Gruszka, Adam Hampshire, Roger A Barker, et al.Neurorehabilitation|February 11, 2020
Parkinson's disease and spiritualityClare Redfern, Sarah L Mason, Roger A Barker, et al.Expert Opinion on Investigational Drugs|August 4, 2020
Huntingtin-lowering strategies for Huntington's diseaseRoger A Barker, Motoki Fujimaki, Priya Rogers, et al.Journal of Cognitive Neuroscience|March 27, 2009
Top-down attentional control in Parkinson's disease: salient considerationsRoshan Cools, Robert Rogers, Roger A Barker, et al.Pageof 234